These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 414285)

  • 1. Naloxone-induced or postwithdrawal abstinence signs in delta9-tetrahydrocannabinol-tolerant rats.
    Kaymakçalan S; Ayhan IH; Tulunay FC
    Psychopharmacology (Berl); 1977 Dec; 55(3):243-9. PubMed ID: 414285
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibition of naloxone-induced withdrawal in morphine dependent mice by 1-trans-delta9-tetrahydrocannabinol.
    Bhargava HN
    Eur J Pharmacol; 1976 Mar; 36(1):259-62. PubMed ID: 944134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Time course of the effects of naturally occurring cannabinoids on morphine abstinence syndrome.
    Bhargava HN
    Pharmacol Biochem Behav; 1978 Jan; 8(1):7-11. PubMed ID: 564515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation between the in vivo and an in vitro expression of opiate withdrawal precipitated by naloxone: their antagonism by l-(-)-delta9-tetrahydrocannabinol.
    Frederickson RC; Hewes CR; Aiken JW
    J Pharmacol Exp Ther; 1976 Nov; 199(2):375-84. PubMed ID: 988178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of some cannabinoids on naloxone-precipitated abstinence in morphine-dependent mice.
    Bhargava HN
    Psychopharmacology (Berl); 1976 Sep; 49(3):267-70. PubMed ID: 826944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Morphine and delta 9-tetrahydrocannabinol: tolerance to the stimulus effects.
    Hirschhorn ID; Rosecrans JA
    Psychopharmacologia; 1974 Apr; 36(3):243-53. PubMed ID: 4858714
    [No Abstract]   [Full Text] [Related]  

  • 7. Attenuation of precipitated abstinence in methadone-dependent rats by delta 9-THC.
    Hine B; Torrelio M; Gershon S
    Psychopharmacol Commun; 1975; 1(3):275-83. PubMed ID: 1241452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tolerance to the cardiovascular effects of delta9-tetrahydrocannabinol in the rat.
    Adams MD; Chait LD; Earnhardt JT
    Br J Pharmacol; 1976 Jan; 56(1):43-8. PubMed ID: 1252665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of morphine and delta-9-tetrahydrocannabinol on motor activity in rats.
    Tulunay FC; Ayhan IH; Sparber SB
    Psychopharmacology (Berl); 1982; 78(4):358-60. PubMed ID: 6296906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Open-field behavior and acquisition of discriminative response control in delta 9-THC.
    Järbe TU; Henriksson BG
    Experientia; 1973 Oct; 29(10):1251-3. PubMed ID: 4758932
    [No Abstract]   [Full Text] [Related]  

  • 11. Morphine-dependent rats: blockade of precipitated abstinence by tetrahydrocannabinol.
    Hine B; Friedman E; Torrelio M; Gershon S
    Science; 1975 Feb; 187(4175):443-5. PubMed ID: 1167428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Naloxone-induced abstinence syndromes in morphine-treated mice.
    Kamei C; Ueki S
    Jpn J Pharmacol; 1974 Aug; 24(4):655-7. PubMed ID: 4477249
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of long-term administration and withdrawal of tetrahydrocannabinols (delta 8-THC and delta 9-THC) on open-field behavior in rats.
    Sjödén PO; Järbe TU; Henriksson BG
    Pharmacol Biochem Behav; 1973; 1(3):243-9. PubMed ID: 4798094
    [No Abstract]   [Full Text] [Related]  

  • 14. Anandamide decreases naloxone-precipitated withdrawal signs in mice chronically treated with morphine.
    Vela G; Ruiz-Gayo M; Fuentes JA
    Neuropharmacology; 1995 Jun; 34(6):665-8. PubMed ID: 7566503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of agonist-antagonist interaction on the development of tolerance and dependence.
    Cochin J; Mushlin BE
    Ann N Y Acad Sci; 1976; 281():244-51. PubMed ID: 190935
    [No Abstract]   [Full Text] [Related]  

  • 16. Tetrahydrocannabinol-attenuated abstinence and induced rotation in morphine-dependent rats: possible involvement of dopamine.
    Hine B; Friedman E; Torrelio M; Gershon S
    Neuropharmacology; 1975 Aug; 14(8):607-10. PubMed ID: 1237098
    [No Abstract]   [Full Text] [Related]  

  • 17. Acute and chronic effects on rats of (-) 1 -trans-tetrahydrocannabinol on unlearned motor tasks.
    Potvin RJ; Fried PA
    Psychopharmacologia; 1972; 26(4):369-78. PubMed ID: 4674065
    [No Abstract]   [Full Text] [Related]  

  • 18. Opiate dependence following acute injections of morphine and naloxone: the assessment of various withdrawal signs.
    Ritzmann RF
    Pharmacol Biochem Behav; 1981 Apr; 14(4):575-7. PubMed ID: 7195040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The attenuation of delta 9-tetrahydrocannabinol and morphine of the quasi-morphine withdrawal syndrome in rats.
    Zaluzny SG; Chesher GB; Jackson DM; Malor R
    Psychopharmacology (Berl); 1979 Mar; 61(2):207-16. PubMed ID: 86997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Behavioral and molecular changes elicited by acute administration of SR141716 to Delta9-tetrahydrocannabinol-tolerant rats: an experimental model of cannabinoid abstinence.
    González S; Fernández-Ruiz J; Di Marzo V; Hernández M; Arévalo C; Nicanor C; Cascio MG; Ambrosio E; Ramos JA
    Drug Alcohol Depend; 2004 May; 74(2):159-70. PubMed ID: 15099659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.